These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 28732245)
1. Interleukin-4 receptor-targeted delivery of Bcl-xL siRNA sensitizes tumors to chemotherapy and inhibits tumor growth. Guruprasath P; Kim J; Gunassekaran GR; Chi L; Kim S; Park RW; Kim SH; Baek MC; Bae SM; Kim SY; Kim DK; Park IK; Kim WJ; Lee B Biomaterials; 2017 Oct; 142():101-111. PubMed ID: 28732245 [TBL] [Abstract][Full Text] [Related]
2. Folate-decorated hydrophilic three-arm star-block terpolymer as a novel nanovehicle for targeted co-delivery of doxorubicin and Bcl-2 siRNA in breast cancer therapy. Qian J; Xu M; Suo A; Xu W; Liu T; Liu X; Yao Y; Wang H Acta Biomater; 2015 Mar; 15():102-16. PubMed ID: 25545322 [TBL] [Abstract][Full Text] [Related]
3. Enhanced delivery of liposomes to lung tumor through targeting interleukin-4 receptor on both tumor cells and tumor endothelial cells. Chi L; Na MH; Jung HK; Vadevoo SM; Kim CW; Padmanaban G; Park TI; Park JY; Hwang I; Park KU; Liang F; Lu M; Park J; Kim IS; Lee BH J Control Release; 2015 Jul; 209():327-36. PubMed ID: 25979323 [TBL] [Abstract][Full Text] [Related]
4. An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma. Shen M; Gong F; Pang P; Zhu K; Meng X; Wu C; Wang J; Shan H; Shuai X Int J Nanomedicine; 2012; 7():3319-32. PubMed ID: 22802690 [TBL] [Abstract][Full Text] [Related]
5. Branched Polyethylenimine-Superparamagnetic Iron Oxide Nanoparticles (bPEI-SPIONs) Improve the Immunogenicity of Tumor Antigens and Enhance Th1 Polarization of Dendritic Cells. Hoang MD; Lee HJ; Lee HJ; Jung SH; Choi NR; Vo MC; Nguyen-Pham TN; Kim HJ; Park IK; Lee JJ J Immunol Res; 2015; 2015():706379. PubMed ID: 26221615 [TBL] [Abstract][Full Text] [Related]
6. Polyethylenimine modified with 2,3-dimethylmaleic anhydride potentiates the antitumor efficacy of conventional chemotherapy. Huang X; Cao J; Zhang Y; Liu T; Yan H Mater Sci Eng C Mater Biol Appl; 2019 Sep; 102():558-568. PubMed ID: 31147028 [TBL] [Abstract][Full Text] [Related]
7. Biodistribution and Toxicity Assessment of Superparamagnetic Iron Oxide Nanoparticles In Vitro and In Vivo. Yu Q; Xiong XQ; Zhao L; Xu TT; Bi H; Fu R; Wang QH Curr Med Sci; 2018 Dec; 38(6):1096-1102. PubMed ID: 30536075 [TBL] [Abstract][Full Text] [Related]
8. Pulmonary Codelivery of Doxorubicin and siRNA by pH-Sensitive Nanoparticles for Therapy of Metastatic Lung Cancer. Xu C; Wang P; Zhang J; Tian H; Park K; Chen X Small; 2015 Sep; 11(34):4321-33. PubMed ID: 26136261 [TBL] [Abstract][Full Text] [Related]
9. MR traceable delivery of p53 tumor suppressor gene by PEI-functionalized superparamagnetic iron oxide nanoparticles. Lee HJ; Nguyen YT; Muthiah M; Vu-Quang H; Namgung R; Kim WJ; Yu MK; Jon S; Lee IK; Jeong YY; Park IK J Biomed Nanotechnol; 2012 Jun; 8(3):361-71. PubMed ID: 22764405 [TBL] [Abstract][Full Text] [Related]
10. PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer. Nagesh PKB; Johnson NR; Boya VKN; Chowdhury P; Othman SF; Khalilzad-Sharghi V; Hafeez BB; Ganju A; Khan S; Behrman SW; Zafar N; Chauhan SC; Jaggi M; Yallapu MM Colloids Surf B Biointerfaces; 2016 Aug; 144():8-20. PubMed ID: 27058278 [TBL] [Abstract][Full Text] [Related]
11. Elucidating the role of free polycations in gene knockdown by siRNA polyplexes. Klauber TC; Søndergaard RV; Sawant RR; Torchilin VP; Andresen TL Acta Biomater; 2016 Apr; 35():248-59. PubMed ID: 26884277 [TBL] [Abstract][Full Text] [Related]
12. Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer. Mu P; Nagahara S; Makita N; Tarumi Y; Kadomatsu K; Takei Y Int J Cancer; 2009 Dec; 125(12):2978-90. PubMed ID: 19422046 [TBL] [Abstract][Full Text] [Related]
13. Superparamagnetic iron oxide nanoparticles modified with polyethylenimine and galactose for siRNA targeted delivery in hepatocellular carcinoma therapy. Yang Z; Duan J; Wang J; Liu Q; Shang R; Yang X; Lu P; Xia C; Wang L; Dou K Int J Nanomedicine; 2018; 13():1851-1865. PubMed ID: 29618926 [TBL] [Abstract][Full Text] [Related]
14. Mono-methoxy-poly(3-hydroxybutyrate-co-4-hydroxybutyrate)-graft-hyper-branched polyethylenimine copolymers for siRNA delivery. Zhou L; Chen Z; Chi W; Yang X; Wang W; Zhang B Biomaterials; 2012 Mar; 33(7):2334-44. PubMed ID: 22154621 [TBL] [Abstract][Full Text] [Related]
15. Targeting the IL-4/IL-13 signaling pathway sensitizes Hodgkin lymphoma cells to chemotherapeutic drugs. Natoli A; Lüpertz R; Merz C; Müller WW; Köhler R; Krammer PH; Li-Weber M Int J Cancer; 2013 Oct; 133(8):1945-54. PubMed ID: 23553437 [TBL] [Abstract][Full Text] [Related]
16. Enhanced inhibition of bladder cancer cell growth by simultaneous knockdown of antiapoptotic Bcl-xL and survivin in combination with chemotherapy. Kunze D; Erdmann K; Froehner M; Wirth MP; Fuessel S Int J Mol Sci; 2013 Jun; 14(6):12297-312. PubMed ID: 23749114 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of antiapoptotic genes in breast cancer cells by siRNA loaded into hybrid nanoparticles. de Mello LJ; Souza GR; Winter E; Silva AH; Pittella F; Creczynski-Pasa TB Nanotechnology; 2017 Apr; 28(17):175101. PubMed ID: 28230534 [TBL] [Abstract][Full Text] [Related]
18. Characterization of polyethylene glycol-grafted polyethylenimine and superparamagnetic iron oxide nanoparticles (PEG-g-PEI-SPION) as an MRI-visible vector for siRNA delivery in gastric cancer in vitro and in vivo. Chen Y; Lian G; Liao C; Wang W; Zeng L; Qian C; Huang K; Shuai X J Gastroenterol; 2013 Jul; 48(7):809-21. PubMed ID: 23179610 [TBL] [Abstract][Full Text] [Related]
19. siRNA-mediated Bcl-2 and Bcl-xl gene silencing sensitizes human hepatoblastoma cells to chemotherapeutic drugs. Lei XY; Zhong M; Feng LF; Zhu BY; Tang SS; Liao DF Clin Exp Pharmacol Physiol; 2007; 34(5-6):450-6. PubMed ID: 17439414 [TBL] [Abstract][Full Text] [Related]
20. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells. Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]